1. Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial. (November 2022) Authors: Hepprich, Matthias; Mudry, Jonathan M.; Gregoriano, Claudia; Jornayvaz, Francois R.; Carballo, Sebastian; Wojtusciszyn, Anne; Bart, Pierre-Alexandre; Chiche, Jean-Daniel; Fischli, Stefan; Baumgartner, Thomas; Cavelti-Weder, Claudia; Braun, Dominique L.; Günthard, Huldrych F.; Beuschlein, Felix; C... Journal: EClinicalMedicine Issue: Volume 53(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗